Tilray Inc (TLRY : TSX)
Common Stock
Follow TLRY
TLRY
Tilray Inc
Performance
1 Day
-4.02%
1 Week
-17.53%
1 Month
-21.96%
YTD
-74.98%
The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.
Key Statistics
Market Cap
$493.61M
52W High
$21.57
52W Low
$3.33
P/E Ratio
-
50 Day MA
$4.81
200 Day MA
$7.20
Beta
2.06
Dividend Yield
-
WA Score
How TLRY stacks up against 944 Canadian stocks
out of 99
- Value3
Not profitable over the last 12 months.
- Quality
- Momentum13
−75.0% this year, below its 200-day average, 0% of the way up its 52-week range.
- Analysts
- Insiders
Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks
Performance history
TLRY returns since 2023
Tilray Inc has traded since Nov 2023 in our data, with 1 up year out of 2 full calendar years. Its deepest fall was −87.0% (Apr 2024 to Jun 2025).
1 year / yr
+133.6%
3 years / yr
+11.8%
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*+32.5%
- 2024−37.9%
- 2025+553.2%
- 2026*−73.1%
* Partial year (first year of data, or year to date).
$10,000 invested in TLRY
- 1 year ago$23,357
- 2023 (start of our data)$14,459
- Best year
- 2025: +553.2%
- Worst year
- 2024: −37.9%
- All-time high in our data
- $19 on Dec 16, 2025 · now −82.5%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.
Earnings
TLRY earnings history
Tilray Inc beat the EPS estimate in 2 of its last 4 reported quarters.
Next report
Jan 7, 2027 · before open
| Quarter ending | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Aug 31, 2026 | Oct 8, 2026 | −$0.02 | −$0.14 | +85.7% |
| May 31, 2026 | Jul 28, 2026 | $0.05 | $0.21 | −76.2% |
| Feb 28, 2026 | Apr 1, 2026 | $0.02 | $0.07 | −71.4% |
| Nov 30, 2025 | Jan 8, 2026 | −$0.02 | — | — |
| Aug 31, 2025 | Oct 9, 2025 | −$0.00 | −$0.03 | +98.7% |
| May 31, 2025 | Jul 28, 2025 | $0.02 | $0.01 | +100.0% |
| Feb 28, 2025 | Apr 8, 2025 | −$0.87 | −$0.33 | −163.6% |
| Nov 30, 2024 | Jan 10, 2025 | −$0.03 | −$0.13 | +76.9% |
EPS as reported vs consensus estimate. TSX earnings calendar →
Awesome Portfolio™
Looking past TLRY? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/16/2026 | $3.42 | $3.42 | $3.33 | $3.34 | $3.34 | 602,210 |
| 11/13/2026 | $3.55 | $3.60 | $3.44 | $3.48 | $3.48 | 286,046 |
| 11/12/2026 | $3.66 | $3.66 | $3.52 | $3.53 | $3.53 | 554,311 |
| 11/11/2026 | $3.78 | $3.82 | $3.57 | $3.71 | $3.71 | 737,044 |
| 11/10/2026 | $4.04 | $4.05 | $3.73 | $3.76 | $3.76 | 734,432 |
| 11/9/2026 | $4.15 | $4.15 | $3.97 | $4.05 | $4.05 | 605,023 |
| 11/6/2026 | $3.96 | $4.15 | $3.89 | $4.12 | $4.12 | 467,395 |
| 11/5/2026 | $4.11 | $4.16 | $3.80 | $3.93 | $3.93 | 717,771 |
| 11/4/2026 | $3.87 | $4.18 | $3.87 | $4.15 | $4.15 | 987,084 |
| 11/3/2026 | $3.64 | $3.83 | $3.62 | $3.72 | $3.72 | 1,197,885 |
Analyst Price Targets
Based on analyst covering TLRY · as of Nov 17, 2026
Wall Street analysts forecast TLRY stock price to rise 70.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.69
+70.5% Upside
Previously C$5.98 on Nov 11, 2026
Current Price
C$3.34
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TLRY's historical volatility
30-Day Vol
65.1%
Annualized
90-Day Vol
54.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.79
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.15 | C$2.51 – C$3.94 |
| 60 trading days | C$2.97 | C$2.16 – C$4.07 |
| 90 trading days | C$2.79 | C$1.89 – C$4.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Tilray Inc
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Shock Top, Montauk Brewing, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point, Alpine, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Cruisies, Atwater Brewery, Hi-ball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Financials
- Revenue (TTM)
- $963.10M
- EBITDA
- $12.69M
- Profit Margin
- -17.05%
- ROE (TTM)
- -9.38%
- EPS (Diluted)
- -1.96
- Book Value
- 15.85
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
🔄 Recent Splits
1-for-10
Dec 2, 2025
Free newsletter
The Saturday TSX Wrap
The week on the TSX, in five minutes
- The biggest gainers and losers, and why they moved
- Sector and momentum moves at a glance
- The Canadian market stories you missed
Explore More
Common Questions About TLRY
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| HWO | High Arctic Energy Services Inc. | $1.74 | +29.85% |
| AAV | Advantage Oil & Gas Ltd. | $13.45 | +23.74% |
| LUC | Lucara Diamond Corp | $0.13 | +13.64% |
| T | Telus Corp | $13.70 | +12.85% |
| FRX | Fennec Pharmaceuticals Inc | $18.35 | +10.81% |
| KEL | Kelt Exploration Ltd. | $12.72 | +10.70% |
| NVO | Novo Resources Corp | $0.07 | +8.33% |
| ELO | Eloro Resources Ltd. | $1.23 | +7.89% |
Free with a Wealth Awesome account
Keep analysing TLRY, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.
